This announcement is a separate document:
Delta-Fly Pharma：DFP-10917の臨床第3相比較試験の中間解析状況に関するお知らせ
Delta-Fly Pharma: Notice regarding the interim analysis status of the DFP-10917 clinical phase 3 comparative trial
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.